Product Information
DEXTROAMPHETAMINE 10 MG TAB is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $0.3733 per EA under NDC 52536051003. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Oct 25, 2011. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536051003
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA090533FDA Approved
10/25/2011
TE Code
AA
On Market Since
7/20/2012
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE 10 MG TAB has been published 237 times since Mar 23, 2022, and over the history we have for it it has risen 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3733 per EA |
|---|---|
| All-time high | $0.5885 (Sep 11, 2024) |
| All-time low | $0.2728 (May 18, 2022) |
| 52-week high | $0.5882 |
| 52-week low | $0.3527 |
| Median price | $0.4255 |
| Average price | $0.4393 |
| Largest weekly change | +61.4% (Aug 21, 2024) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Wilshire Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE 10 MG TAB, manufactured by Wilshire Pharmaceuticals Inc., is $0.3733 per EA (NDC 52536051003), effective Sep 30, 2026.
How has the price of DEXTROAMPHETAMINE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE 10 MG TAB has risen 24.2%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE 10 MG TAB?
Since Mar 23, 2022, the NADAC for DEXTROAMPHETAMINE 10 MG TAB has ranged from a low of $0.2728 (May 18, 2022) to a high of $0.5885 (Sep 11, 2024), with a median of $0.4255 per EA.
Are there cheaper alternatives to DEXTROAMPHETAMINE 10 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMPHETAMINE 10 MG TAB, is $0.3729 per EA — about 0% below DEXTROAMPHETAMINE 10 MG TAB.
Who manufactures DEXTROAMPHETAMINE 10 MG TAB?
DEXTROAMPHETAMINE 10 MG TAB (NDC 52536051003) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.